Right to Try Individualized Treatments.

This bill allows patients with life-threatening or severely debilitating conditions in North Carolina to access custom-made investigational drugs, biological products, or devices that are not yet approved by the federal government. To qualify, a patient must have a doctor confirm that standard FDA-approved treatments are unlikely to help and must provide written informed consent acknowledging the risks and potential costs. The law requires that the patient or their guardian understands they are personally responsible for any expenses related to the treatment unless a separate contract states otherwise. Additionally, the bill clarifies that using these individualized treatments may temporarily remove a patient's eligibility for hospice care, though that eligibility can be restored if the treatment stops.